MONDAY 21 November 2022
NON ECM PLENARY SESSIONS
RIUNIONE DEI GRUPPI DI LAVORO DEI PROGETTI GOLD E MULTIMORBIDITA’
09:00-13:00 GOLD (COPD) + MULTIMORBIDITY
Chairmen Raffaele F. Antonelli Incalzi, Enrico M. Clini, Lorenzo Corbetta, Dario Manfellotto and Alberto Papi
09:00 Ian D. Pavord
COPD, ASTHMA, CONCOMITANT COPD AND ASTHMA, OR CHRONIC RESPIRATORY DISEASE?
09:40 Bartolome Celli
NEED FOR A NEW DEFINITION OF COPD?
10:20 Claus F. Vogelmeier
MANAGEMENT OF COMORBIDITIES OF COPD AT STABLE STATE AND DURING EXACERBATIONS
11:00 Gerard J. Criner
UPDATE ON NON-PHARMACOLOGIC MANAGEMENT OF COPD: MECHANICAL VENTILATION AND INTERVENTIONAL ENDOSCOPY (EG RHEOPLASTIC)
11:15-11:45 OPEN COFFEE Hotel Lobby
11:40-13:00 BREAKING NEWS IN COPD/MULTIMORBIDITY
FROM THE GOLD 2023 DOCUMENT:
2022 GOLD INTERNATIONAL COPD CONFERENCE SATELLITE SYMPOSIUM
Session devoted to the discussion of updates reported in the document “Global Initiative on bstructive Lung Disease 2023”, published on November 16, during the 2022 GOLD International Conference held in Philadelphia.
Chairman Leonardo M. Fabbri
Speaker Alberto Papi
11:40-11:55 SUMMARY OF THE MOST SIGNIFICANT UPDATES OF THE GOLD 2023 DOCUMENT
11:55-13:00 DISCUSSION
13:00-14:00 LUNCH Hotel Restaurants Arno and Fiesole
14:00-16:00 COLLABORATION BETWEEN ACADEMIC SCIENTISTS AND PHARMA INDUSTRY SCIENTISTS IN THE DEVELOPMENT OF NOVEL TREATMENTS FOR ASTHMA, ALLERGY/RHINITIS, COPD, MULTIMORBIDITY: PANEL DISCUSSION
Conductors Leonardo M. Fabbri, Pierluigi Paggiaro, Alberto Papi and Giovanni Passalacqua
RISK REDUCTION STRATEGIES IN COPD BEYOND INHALED CORTICOSTEROIDS
David A. Lipson
Vice President, Respiratory Disease Area Lead
GLAXOSMITHKLINE
TRANSFORMING HEALTHCARE IN RESPIRATORY
Maria Belvisi
SVP, Early Research and Development, Respiratory & Immunology
Biopharmaceuticals R&D
ASTRAZENECA
RESPIRATORY R&D AT CHIESI: TOWARDS PRECISION MEDICINE
Thomas Eichholtz
Head of Global R&D
CHIESI FARMACEUTICI
THE EFFECTS OF TYPE 2 INFLAMMATION ON NEUROIMMUNE FUNCTION
Rahin Ebrahimzadeh
Global Medical Type 2 Associate Director
Global Divisions Biologics
SANOFI
ECM PLENARY SESSIONS
16:00-17:15 MULTIPLE TREATMENT OF SEVERE COPD AND COMORBIDITIES
Chairmen Raffaele Antonelli Incalzi, Alfredo Chetta and Manuel G. Cosio
Alvar Agusti
TREATABLE TRAITS APPROACH TO THE MANAGEMENT OF CHRONIC RESPIRATORY DISEASES
Klaus F. Rabe
BIOLOGICS IN COPD
Lowie E.G.W. Vanfleteren
HOLISTIC MANAGEMENT OF SEVERE COPD AND COMORBIDITIES
17:15-17:45 COFFEE BREAK Hotel Lobby
17:45-19:00 COPD PHENOTYPES
Chairpersons Sergio A. Harari, Paolo Palange and Marina Saetta
John Hurst
THE BRONCHIECTASIS-COPD PHENOTYPE
Marc Humbert
THE COPD-PULMONARY HYPERTENSION PHENOTYPE
Andrea S. Gershon
COPD WITH HISTORY OF ASTHMA: IS IT A DISTINCT PHENOTYPE?
19:00-19:30 PLENARY LECTURE
Chairmen Eugenio Baraldi, Marco Confalonieri and Diego G. Peroni
Andrew Bush
DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (DOHAD)
TUESDAY 22 November 2022
ECM PLENARY SESSION
08:00-08:50 PLENARY LECTURES
Chairmen Matteo Bonini, Leonardo M. Fabbri
Monica Kraft
SMALL AIRWAYS IN ASTHMA: THE ATLANTIS STUDY
Monica Kraft
THERMOPLASTY
NON ECM PLENARY SESSION
RIUNIONE DEL GRUPPO DI LAVORO DEL PROGETTO ARIA
08:50-11.30 ARIA (Rinite)
Chairmen Giovanni Passalacqua, Carlo Lombardi, Vincenzo Patella and Antonio Spanevello
08:50 Charles R.W. Beasley
THE NEW ZEALAND ASTHMA GUIDELINES-SIMILARITIES/DIFFERENCES WITH ARIA/GINA
09:15 Lorenzo Cosmi
PATHOPHYSIOLOGY OF CHRONIC SINUSITIS WITH NASAL POLYPS
09:40 Claus Bachert
MANAGEMENT OF CHRONIC SINUSITIS WITH NASAL POLYPS
10:05-11:30 GROUP DISCUSSION: BREAKING NEWS IN ARIA
11:00-11:30 OPEN COFFEE Hotel Lobby
NON ECM PLENARY SESSION
RIUNIONE DEL GRUPPO DI LAVORO DEL PROGETTO GINA
11:30-13:30 GINA (Asma)
Chairpersons Pierluigi Paggiaro, Bianca Beghè, Sergio Bonini and Gianenrico Senna
11:30 Helen K. Reddel
2022 UPDATE OF THE GINA DOCUMENT
11:55 Marteen van den Berge
RATIONALE OF SMART APPROACH IN ASTHMA AND COPD
12:20 Alberto Papi
MANAGEMENT OF MODERATE TO SEVERE ASTHMA: SMART VS NON-SMART
12:20-13:30 GROUP DISCUSSION: BREAKING NEWS IN GINA
13:30-14:30 LUNCH Hotel Restaurants Arno and Fiesole
ECM PLENARY SESSIONS
14:30-15:30 TREATMENT OF DIFFICULT TO CONTROL ASTHMA
Chairmen Nunzio Crimi, Alberto Papi and Adriano Vaghi
Paolo Spagnolo
MACROLIDE IN CHRONIC RESPIRATORY DISEASES
Fabio Luigi Massimo Ricciardolo
MANAGEMENT OF T2 LOW ASTHMA
15:30-16:00 PLENARY LECTURE
Chairmen Eugenio Baraldi, Dario Olivieri and Giovanni Passalacqua
William W. Busse
MICROBIOME AND ASTHMA EXACERBATIONS
16:00-16:30 CME QUESTIONNAIRE AND FAREWELL